Latest Insider Transactions at Privia Health Group, Inc. (PRVA)
This section provides a real-time view of insider transactions for Privia Health Group, Inc. (PRVA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Privia Health Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Privia Health Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2022
|
David Mountcastle EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,833
+37.58%
|
-
|
|
Mar 28
2022
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-17.04%
|
$500,000
$25.09 P/Share
|
|
Mar 28
2022
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.56%
|
$40,000
$2.0 P/Share
|
|
Mar 28
2022
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
10,000
-26.74%
|
$250,000
$25.09 P/Share
|
|
Mar 28
2022
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.1%
|
$20,000
$2.0 P/Share
|
|
Feb 22
2022
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
10,000
-26.74%
|
$250,000
$25.32 P/Share
|
|
Feb 22
2022
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.1%
|
$20,000
$2.0 P/Share
|
|
Feb 22
2022
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-17.04%
|
$500,000
$25.3 P/Share
|
|
Feb 22
2022
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.56%
|
$40,000
$2.0 P/Share
|
|
Feb 10
2022
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,288
-2.58%
|
$132,200
$25.02 P/Share
|
|
Feb 10
2022
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,288
+4.9%
|
$10,576
$2.0 P/Share
|
|
Jan 05
2022
|
David Mountcastle EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,391
-36.93%
|
$409,775
$25.53 P/Share
|
|
Jan 05
2022
|
David Mountcastle EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,554
+32.69%
|
$43,108
$2.0 P/Share
|
|
Jan 05
2022
|
Jeffrey Scott Sherman EVP, CFO and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
61,307
+50.0%
|
-
|
|
Dec 22
2021
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-17.04%
|
$500,000
$25.14 P/Share
|
|
Dec 22
2021
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.56%
|
$40,000
$2.0 P/Share
|
|
Dec 22
2021
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
10,000
-26.74%
|
$250,000
$25.14 P/Share
|
|
Dec 22
2021
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.1%
|
$20,000
$2.0 P/Share
|
|
Dec 22
2021
|
David Mountcastle EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-52.27%
|
$625,000
$25.04 P/Share
|
|
Nov 23
2021
|
Pamplona Capital Partners Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,791,175
-8.21%
|
$48,361,725
$27.7 P/Share
|
|
Nov 23
2021
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
157,929
-61.86%
|
$4,264,083
$27.7 P/Share
|
|
Nov 23
2021
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
110,104
+30.13%
|
$220,208
$2.0 P/Share
|
|
Nov 23
2021
|
Matthew Shawn Morris Director |
SELL
Open market or private sale
|
Direct |
339,062
-73.58%
|
$9,154,674
$27.7 P/Share
|
|
Nov 23
2021
|
Matthew Shawn Morris Director |
BUY
Exercise of conversion of derivative security
|
Direct |
339,062
+42.39%
|
$678,124
$2.0 P/Share
|
|
Nov 23
2021
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
28,910
-51.35%
|
$780,570
$27.7 P/Share
|
|
Nov 23
2021
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
28,910
+33.93%
|
$57,820
$2.0 P/Share
|
|
Nov 23
2021
|
Jeffrey B Butler Director |
SELL
Open market or private sale
|
Direct |
429,877
-8.2%
|
$11,606,679
$27.7 P/Share
|
|
Nov 23
2021
|
William M Sullivan Director |
SELL
Open market or private sale
|
Indirect |
568,055
-8.21%
|
$15,337,485
$27.7 P/Share
|
|
Nov 23
2021
|
Mbd Advisors, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,505,732
-8.04%
|
$67,654,764
$27.7 P/Share
|
|
Nov 23
2021
|
Jeffrey Daniel Bernstein Director |
SELL
Open market or private sale
|
Indirect |
2,505,732
-8.04%
|
$67,654,764
$27.7 P/Share
|
|
Nov 23
2021
|
Goldman Sachs Group Inc > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,505,732
-8.04%
|
$67,654,764
$27.7 P/Share
|
|
Nov 22
2021
|
Matthew Shawn Morris Director |
SELL
Open market or private sale
|
Direct |
29,228
-19.36%
|
$818,384
$28.12 P/Share
|
|
Nov 22
2021
|
Matthew Shawn Morris Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,228
+16.22%
|
$58,456
$2.0 P/Share
|
|
Nov 16
2021
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.67%
|
$150,000
$30.25 P/Share
|
|
Nov 16
2021
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.22%
|
$10,000
$2.0 P/Share
|
|
Nov 09
2021
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.46%
|
$232,500
$31.25 P/Share
|
|
Nov 09
2021
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.68%
|
$15,000
$2.0 P/Share
|
|
Nov 05
2021
|
David Mountcastle EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
28,079
-18.79%
|
$758,133
$27.7 P/Share
|
|
Nov 04
2021
|
Matthew Shawn Morris Director |
SELL
Open market or private sale
|
Direct |
1,200
-0.98%
|
$33,600
$28.07 P/Share
|
|
Nov 04
2021
|
Matthew Shawn Morris Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+0.97%
|
$2,400
$2.0 P/Share
|
|
Nov 02
2021
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.33%
|
$125,000
$25.51 P/Share
|
|
Nov 02
2021
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.22%
|
$10,000
$2.0 P/Share
|
|
Jun 30
2021
|
Jaewon Ryu Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,944
+50.0%
|
-
|
|
May 11
2021
|
Brighton Health Group Holdings, LLC |
SELL
Other acquisition or disposition
|
Direct |
79,178,464
-100.0%
|
-
|
|
May 04
2021
|
Goldman Sachs Group Inc > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50
-0.0%
|
$1,700
$34.93 P/Share
|
|
May 04
2021
|
Mbd Advisors, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50
-0.0%
|
$1,700
$34.93 P/Share
|
|
May 03
2021
|
Pamplona Capital Partners Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,700,000
-17.42%
|
$350,700,000
$21.62 P/Share
|
|
May 03
2021
|
Jeffrey Daniel Bernstein Director |
SELL
Open market or private sale
|
Indirect |
16,700,000
-17.42%
|
$350,700,000
$21.62 P/Share
|
|
May 03
2021
|
Brighton Health Group Holdings, LLC |
SELL
Open market or private sale
|
Direct |
16,700,000
-17.42%
|
$350,700,000
$21.62 P/Share
|
|
May 03
2021
|
Goldman Sachs Group Inc > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,700,000
-17.42%
|
$350,700,000
$21.62 P/Share
|